Mon compte

connexion

inscription

   Publicité ▼


 » 
allemand anglais arabe bulgare chinois coréen croate danois espagnol espéranto estonien finnois français grec hébreu hindi hongrois islandais indonésien italien japonais letton lituanien malgache néerlandais norvégien persan polonais portugais roumain russe serbe slovaque slovène suédois tchèque thai turc vietnamien
allemand anglais arabe bulgare chinois coréen croate danois espagnol espéranto estonien finnois français grec hébreu hindi hongrois islandais indonésien italien japonais letton lituanien malgache néerlandais norvégien persan polonais portugais roumain russe serbe slovaque slovène suédois tchèque thai turc vietnamien

définition - alpha 1-Antitrypsin

alpha 1-Antitrypsin (n.)

1.(MeSH)Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Commonly referred to as alpha 1-proteinase inhibitor (A1PI), it exists in over 30 different biochemical variant forms known collectively as the Pi (protease inhibitor) system. Hereditary A1PI deficiency is associated with PULMONARY EMPHYSEMA.

alpha-1-antitrypsin (n.)

1.(MeSH)Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Commonly referred to as alpha 1-proteinase inhibitor (A1PI), it exists in over 30 different biochemical variant forms known collectively as the Pi (protease inhibitor) system. Hereditary A1PI deficiency is associated with PULMONARY EMPHYSEMA.

   Publicité ▼

définition (complément)

voir la définition de Wikipedia

synonymes - alpha 1-Antitrypsin

   Publicité ▼

dictionnaire analogique


Wikipedia

Alpha 1-antitrypsin

                   
Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1

Crystal structure of serpin A1 (red) in an inhibitory complex with pancreatic elastase (blue). Rendered from PDB 2D26.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols SERPINA1; A1A; A1AT; AAT; PI; PI1; PRO2275; alpha1AT
External IDs OMIM107400 MGI891971 HomoloGene20103 GeneCards: SERPINA1 Gene
RNA expression pattern
PBB GE SERPINA1 211429 s at tn.png
PBB GE SERPINA1 202833 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 5265 20700
Ensembl ENSG00000197249 ENSMUSG00000066366
UniProt P01009 P07758
RefSeq (mRNA) NM_000295.4 NM_001252569.1
RefSeq (protein) NP_000286.3 NP_001239498.1
Location (UCSC) Chr 14:
94.84 – 94.86 Mb
Chr 12:
105.09 – 105.1 Mb
PubMed search [1] [2]

Alpha 1-Antitrypsin or α1-antitrypsin (A1AT) is a protease inhibitor belonging to the serpin superfamily. It is generally known as serum trypsin inhibitor. Alpha 1-antitrypsin is also referred to as alpha-1 proteinase inhibitor (A1PI) because it inhibits a wide variety of proteases.[1] It protects tissues from enzymes of inflammatory cells, especially neutrophil elastase, and has a reference range in blood of 1.5 - 3.5 gram/liter (in US the reference range is generally expressed as mg/dL or micromoles), but the concentration can rise manyfold upon acute inflammation.[2] In its absence, neutrophil elastase is free to break down elastin, which contributes to the elasticity of the lungs, resulting in respiratory complications such as emphysema, or COPD (chronic obstructive pulmonary disease) in adults and cirrhosis in adults or children.

Contents

  Function

A1AT is a 52-kDa serpin and, in medicine, it is considered the most prominent serpin; the terms α1-antitrypsin and protease inhibitor (Pi) are often used interchangeably.

Most serpins inactivate enzymes by binding to them covalently, requiring very high levels to perform their function. In the acute phase reaction, a further elevation is required to "limit" the damage caused by activated neutrophil granulocytes and their enzyme elastase, which breaks down the connective tissue fiber elastin.

Like all serine protease inhibitors, A1AT has a characteristic secondary structure of beta sheets and alpha helices. Mutations in these areas can lead to non-functional proteins that can polymerise and accumulate in the liver (infantile hepatic cirrhosis).

  Role in disease

Disorders of this protein include alpha 1-antitrypsin deficiency, a hereditary disorder in which a deficiency of alpha 1-antitrypsin leads to a chronic uninhibited tissue breakdown. This causes the degradation especially of lung tissue, and eventually leads to characteristic manifestations of pulmonary emphysema.[3] Evidence has shown that cigarette smoke can lead to oxidation of methionine 358 of α1-antitrypsin, a residue essential for binding elastase; this is thought to be one of the primary mechanisms by which cigarette smoking (or second-hand smoke) can lead to emphysema. Because A1AT is expressed in the liver, certain mutations in the gene encoding the protein can cause misfolding and impaired secretion, which can lead to liver cirrhosis.

An extremely rare form of Pi, termed PiPittsburgh, functions as an antithrombin (a related serpin), due to a mutation (Met358Arg). One person with this mutation has been reported to have died of a lethal bleeding diathesis.

Liver biopsy will show abundant PAS-positive globules within periportal hepatocytes.

  Nomenclature

The protein was originally named "antitrypsin" because of its ability to covalently bind and irreversibly inactivate the enzyme trypsin in vitro. Trypsin, a type of peptidase, is a digestive enzyme active in the duodenum and elsewhere.

The term alpha-1 refers to the protein's behavior on protein electrophoresis. On electrophoresis, the protein component of the blood is separated by electric current. There are several clusters, the first being albumin, the second being the alpha, the third beta and the fourth gamma (immunoglobulins). The non-albumin proteins are referred to as globulins.

The alpha region can be further divided into two sub-regions, termed "1" and "2". Alpha 1-antitrypsin is the main protein of the alpha-globulin 1 region.

Another name used is alpha-1 proteinase inhibitor1-PI).

  Genetics

The gene is located on the long arm of the fourteenth chromosome (14q32.1).

Over 100 different variants of α1-antitrypsin have been described in various populations. North-Western Europeans are most at risk for carrying one of the most common mutant forms of A1AT, the Z mutation (Glu342Lys on M1A, rs28929474).

  Biochemical Properties

A1AT is a single-chain glycoprotein consisting of 394 amino acids in the mature form and exhibits a number of glycoforms. The three N-linked glycosylations sites are mainly equipped with so-called diantennary N-glycans. However, one particular site shows a considerable amount of heterogeneity since tri- and even tetraantennary N-glycans can be attached to the Asparagine 107 (ExPASy amino acid nomenclature). These glycans carry different amounts of negatively-charged sialic acids, this causes the heterogeneity observed on normal A1AT when analysed by isoelectric focussing. In addition, the fucosylated triantennary N-glycans were shown to have the fucose as part of a so-called Sialyl Lewis x epitope, which could confer this protein particular protein-cell recognition properties. The single cysteine residue of A1AT in position 256 (ExPASy nomenclature) is found to be covalently linked to a free single cysteine by a disulfide bridge.[4]

  Analysis

As protein electrophoresis is imprecise, A1AT is analysed by isoelectric focusing (IEF) in the pH range 4.5-5.5, where the protein migrates in a gel according to its isoelectric point or charge in a pH gradient.

Normal A1AT is termed M, as it is migrates toward the center of such an IEF gel. Other variants are less functional, and are termed A-L and N-Z, dependent on whether they run proximal or distal to the M band. The presence of deviant bands on IEF can signify the presence of alpha 1-antitrypsin deficiency. Since the number of identified mutations has exceeded the number of letters in the alphabet, subscripts have been added to most recent discoveries in this area, as in the Pittsburgh mutation described above.

As every person has two copies of the A1AT gene, a heterozygote with two different copies of the gene may have two different bands showing on electrofocusing, although heterozygote with one null mutant that abolishes expression of the gene will only show one band.

In blood test results, the IEF results are notated as in PiMM, where Pi stands for protease inhibitor and "MM" is the banding pattern of that patient.

Other detection methods include use of enzyme-linked-immuno-sorbent-assays in vitro and radial immunodiffusion.

Alpha 1-antitrypsin levels in the blood depend on the genotype. Some mutant forms fail to fold properly and are, thus, targeted for destruction in the proteasome, whereas others have a tendency to polymerise, being retained in the endoplasmic reticulum. The serum levels of some of the common genotypes are:

  • PiMM: 100% (normal)
  • PiMS: 80% of normal serum level of A1AT
  • PiSS: 60% of normal serum level of A1AT
  • PiMZ: 60% of normal serum level of A1AT
  • PiSZ: 40% of normal serum level of A1AT
  • PiZZ: 10-15% (severe alpha 1-antitrypsin deficiency)

Other rarer forms have been described; in all there are over 80 variants.

  Therapeutic use

Alpha 1-antitrypsin
Systematic (IUPAC) name
Alpha-1-proteinase inhibitor
Clinical data
Pregnancy cat.  ?
Legal status  ?
Routes intravenous
Identifiers
CAS number 9041-92-3 YesY
ATC code B02AB02
DrugBank DB00058
Chemical data
Formula C2001H3130N514O601S10 
Mol. mass 44324.5 g/mol
 YesY (what is this?)  (verify)

Recombinant alpha 1-antitrypsin is not yet commercially available, but is under investigation as a therapy for alpha 1-antitrypsin deficiency.

Therapeutic concentrates are prepared from the blood plasma of blood donors. The US FDA has approved the use of three alpha 1-antitrypsin products derived from a human plasma: Prolastin, Zemaira, and Aralast. These products for intravenous augmention A1AT therapy can cost up to $100,000 per year per patient.[5] They are administered intravenously at a dose of 60 mg/kg once a week.

A recent study analyzed and compared the three FDA-approved products in terms of their primary structure and glycosylation. All three products showed minor differences compared to the normal human plasma A1AT, and are introduced during the specific purifications procedures. However, these detected differences are not believed to have any negative implications to the patients.[6]

Aerosolized-augmented A1AT therapy is under study. This involves inhaling purified human A1AT into the lungs and trapping the A1AT into the lower respiratory tract. This method proves more successful than intravenous-augmented A1AT therapy because intravenous use of A1AT results in only 10%-15% of the A1AT reaching the lower respiratory tract, whereas 25%-45% of A1AT can reach the lower respiratory tract through inhalation[citation needed][citation needed]. However, inhaled A1AT may not reach the elastin fibers in the lung where elastase injury actually occurs. Further study is currently underway.

  History

The possibility of allelic variants of A1AT leading to disease was first investigated by Axelsson and Laurell in 1965.[7]

  See also

  References

  1. ^ Gettins PG (2002). "Serpin structure, mechanism, and function". Chem Rev 102 (12): 4751–804. DOI:10.1021/cr010170. PMID 12475206. 
  2. ^ Kushner, Mackiewicz A (1993). The acute phase response: an overview.. CRC Press. pp. 3–19. 
  3. ^ DeMeo DL, Silverman EK (2004). "α1-Antitrypsin deficiency · 2: Genetic aspects of α1-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk". Thorax 59 (3): 259–64. DOI:10.1136/thx.2003.006502. PMC 1746953. PMID 14985567. //www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1746953. 
  4. ^ Kolarich D, Weber A, Turecek PL, Schwarz HP, Altmann F (2006). "Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms". Proteomics 6 (11): 3369–80. DOI:10.1002/pmic.200500751. PMID 16622833. 
  5. ^ Alkins SA, O'Malley P (2000). "Should health-care systems pay for replacement therapy in patients with alpha(1)-antitrypsin deficiency? A critical review and cost-effectiveness analysis". Chest 117 (3): 875–80. DOI:10.1378/chest.117.3.875. PMID 10713018. 
  6. ^ Kolarich D, Turecek PL, Weber A, Mitterer A, Graninger M, Matthiessen P, Nicolaes GA, Altmann F, Schwarz HP (2006). "Biochemical, molecular characterization, and glycoproteomic analyses of alpha(1)-proteinase inhibitor products used for replacement therapy". Transfusion 46 (11): 1959–77. DOI:10.1111/j.1537-2995.2006.01004.x. PMID 17076852. 
  7. ^ Axelsson U, Laurell CB (1965). "Hereditary variants of serum alpha-1-antitrypsin". Am J Hum Genet 17 (6): 466–72. PMC 1932630. PMID 4158556. //www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1932630. [citation needed]

  Further reading

  External links

   
               

 

Toutes les traductions de alpha 1-Antitrypsin


Contenu de sensagent

  • définitions
  • synonymes
  • antonymes
  • encyclopédie

  • definition
  • synonym

   Publicité ▼

dictionnaire et traducteur pour sites web

Alexandria

Une fenêtre (pop-into) d'information (contenu principal de Sensagent) est invoquée un double-clic sur n'importe quel mot de votre page web. LA fenêtre fournit des explications et des traductions contextuelles, c'est-à-dire sans obliger votre visiteur à quitter votre page web !

Essayer ici, télécharger le code;

SensagentBox

Avec la boîte de recherches Sensagent, les visiteurs de votre site peuvent également accéder à une information de référence pertinente parmi plus de 5 millions de pages web indexées sur Sensagent.com. Vous pouvez Choisir la taille qui convient le mieux à votre site et adapter la charte graphique.

Solution commerce électronique

Augmenter le contenu de votre site

Ajouter de nouveaux contenus Add à votre site depuis Sensagent par XML.

Parcourir les produits et les annonces

Obtenir des informations en XML pour filtrer le meilleur contenu.

Indexer des images et définir des méta-données

Fixer la signification de chaque méta-donnée (multilingue).


Renseignements suite à un email de description de votre projet.

Jeux de lettres

Les jeux de lettre français sont :
○   Anagrammes
○   jokers, mots-croisés
○   Lettris
○   Boggle.

Lettris

Lettris est un jeu de lettres gravitationnelles proche de Tetris. Chaque lettre qui apparaît descend ; il faut placer les lettres de telle manière que des mots se forment (gauche, droit, haut et bas) et que de la place soit libérée.

boggle

Il s'agit en 3 minutes de trouver le plus grand nombre de mots possibles de trois lettres et plus dans une grille de 16 lettres. Il est aussi possible de jouer avec la grille de 25 cases. Les lettres doivent être adjacentes et les mots les plus longs sont les meilleurs. Participer au concours et enregistrer votre nom dans la liste de meilleurs joueurs ! Jouer

Dictionnaire de la langue française
Principales Références

La plupart des définitions du français sont proposées par SenseGates et comportent un approfondissement avec Littré et plusieurs auteurs techniques spécialisés.
Le dictionnaire des synonymes est surtout dérivé du dictionnaire intégral (TID).
L'encyclopédie française bénéficie de la licence Wikipedia (GNU).

Copyright

Les jeux de lettres anagramme, mot-croisé, joker, Lettris et Boggle sont proposés par Memodata.
Le service web Alexandria est motorisé par Memodata pour faciliter les recherches sur Ebay.
La SensagentBox est offerte par sensAgent.

Traduction

Changer la langue cible pour obtenir des traductions.
Astuce: parcourir les champs sémantiques du dictionnaire analogique en plusieurs langues pour mieux apprendre avec sensagent.

 

4708 visiteurs en ligne

calculé en 0,063s

Je voudrais signaler :
section :
une faute d'orthographe ou de grammaire
un contenu abusif (raciste, pornographique, diffamatoire)
une violation de copyright
une erreur
un manque
autre
merci de préciser :